SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-049988
Filing Date
2023-09-19
Accepted
2023-09-19 17:00:17
Documents
2
Period of Report
2023-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1680
2 POA DOCUMENT poa.txt EX-24 4671
  Complete submission text file 0001209191-23-049988.txt   7697
Mailing Address 55 BALDWIN LANE PRINCETON NJ 08540
Business Address
Fiedorek Fred T. (Reporting) CIK: 0001657185 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40489 | Film No.: 231264523

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations